Clinical Trial for the Prevention of Nerve-Damage (Neuropathy) in Black Women with Breast Cancer

Prospective Validation Trial of Taxane Therapy (Docetaxel or Weekly Paclitaxel) and Risk of Chemotherapy-Induced Peripheral Neuropathy in African American Women

 

For more information, visit the EAZ171 Home Page.

Physician and Research Staff Educational Material

This material is intended for promotional use among health care professionals and is NOT intended for use as patient educational material.

Patient Educational Material

Participating sites should note that the Central Institutional Review Board (CIRB) has approved this material.

    • Study Summary for Patients: Study rationale/objectives, details regarding treatment, and a simplified schema in lay language to provide a more visual description of the trial to patients

Recruitment/Awareness Promotional Material

    • Recruitment Communications Plan: Approved language, images, and videos for use by the EAZ171 communication team and individual sites participating in the trial

Information and Assistance from the National Cancer Institute

    • Locations and other information
    • Trained information specialists at the NCI are available to answer cancer-related questions from patients, family members or friends, health care providers, and researchers. Visit the NCI’s Cancer Information Service webpage for contact instructions, including telephone, live chat, email, and mail.

ClinicalTrials.gov ID: NCT04001829

Return to Home Page | Return to EAZ171 Home Page | Review Other Active Trials